Movement Disorders

Safinamide Approved as Adjunctive Therapy for Parkinson's

Safinamide Approved as Adjunctive Therapy for Parkinson's

By

The US FDA has approved safinamide as adjunctive therapy in Parkinson's disease to increase "on" time

Movement Disorder After Foreign Body Ingestion

Movement Disorder After Foreign Body Ingestion

A 10-month-old girl admitted to PICU with sudden onset of movement disorder was found to have ingested a foreign body.

Cerebral Palsy in Full-Term Infants Linked to Maternal Obesity

Cerebral Palsy in Full-Term Infants Linked to Maternal Obesity

While their are other factors more strongly associated with risk of cerebral palsy, maternal obesity is modifiable and therefore should be studied further.

Timed Light Therapy May Benefit Sleep in Parkinson's

Timed Light Therapy May Benefit Sleep in Parkinson's

By

Improvements in excessive daytime sleepiness and daytime alertness were observed in the bright light therapy group.

Parkinsonian Disorder Differentiation Using Blood Biomarker

Parkinsonian Disorder Differentiation Using Blood Biomarker

By

Neurofilament light chain, a blood biomarker, demonstrated high accuracy for distinguishing atypical parkinsonian disorders from Parkinson's disease.

Effect of Depression and Anxiety on Cognition in Parkinson's Disease

Effect of Depression and Anxiety on Cognition in Parkinson's Disease

By

Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.

VIDEO: Dysfunctional Mitochondrial DNA May Play a Role in Parkinson's Disease

VIDEO: Dysfunctional Mitochondrial DNA May Play a Role in Parkinson's Disease

New findings suggest that dysregulation of mitochondrial DNA homeostasis may be a key factor in the pathogenesis of neuronal loss in people with Parkinson's disease.

Cognitive Stress Impacts Levodopa Efficacy in Parkinson's

Cognitive Stress Impacts Levodopa Efficacy in Parkinson's

During cognitive co-activation, the levodopa effect was significantly smaller.

FDA Reviewing Potential Treatment for Levodopa-Induced Dyskinesia

FDA Reviewing Potential Treatment for Levodopa-Induced Dyskinesia

By

The FDA has accepted the NDA for ADS-5102 for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease.

Developing a Model for Predicting Cognitive Impairment in Parkinson's

Developing a Model for Predicting Cognitive Impairment in Parkinson's

By

A combination of age and clinical scores better predicted cognitive impairment than age alone.

Adjunctive Safinamide Increases On Time in Parkinson's Disease

Adjunctive Safinamide Increases On Time in Parkinson's Disease

By

Adjunctive treatment with safinamide helps increase "on" time in patients with Parkinson's disease.

Gene Mutation, Age Linked to Early-Onset Parkinson's Disease

Gene Mutation, Age Linked to Early-Onset Parkinson's Disease

Mutated GCH1 gene was associated with a 23% increased risk of Parkinson's disease, especially in men 50 years or younger.

More Evidence Favoring Inhaled Levodopa for Parkinson's

More Evidence Favoring Inhaled Levodopa for Parkinson's

A powdered version of the common treatment may help to relieve "off" periods.

Parkinson's Intestinal Gel May Cause Nerve Damage

Parkinson's Intestinal Gel May Cause Nerve Damage

By

The small study documented several cases of denervation and increased thermal thresholds in patients treated with LCIG.

Whole Body Vibration, Exercise May Improve Motor Performance In Parkinson's

Whole Body Vibration, Exercise May Improve Motor Performance In Parkinson's

By

Pharmacologic intervention is the current standard of care for Parkinson's disease, yet medications frequently fail to control some symptoms, including tremor and postural instability.

GBA Mutations in Parkinson's May Increase Risk of Dementia

GBA Mutations in Parkinson's May Increase Risk of Dementia

The researchers found that GBA carriers were at greater risk for dementia and death (hazard ratios, 3.16 and 1.85, respectively) than non-carriers.

Statin Therapy Recommended in Parkinson's Patients With Vascular Risks

Statin Therapy Recommended in Parkinson's Patients With Vascular Risks

By

Vascular disease can have a negative impact on cognition and motor phenotype in PD.

Cognitive Training, Transcranial Direct Current Stimulation Improves Cognition in Parkinson's

Cognitive Training, Transcranial Direct Current Stimulation Improves Cognition in Parkinson's

By

Cognitive training and tDCS, alone or combined, appear to benefit cognition and QOL in Parkinson's patients

Gait Characteristics Better Predict Cognitive Decline in Early Parkinson's

Gait Characteristics Better Predict Cognitive Decline in Early Parkinson's

By

The standard MoCA evaluation was unable to predict decline in fluctuating attention and visual memory.

Alternative Therapies Deemed Effective for Parkinson's Symptoms

Alternative Therapies Deemed Effective for Parkinson's Symptoms

By

Over fifty percent of respondents reported using 1 or more alternative therapies.

4th World Parkinson Congress: What to Expect

4th World Parkinson Congress: What to Expect

By

The 4th World Parkinson Congress takes September 20-23, 2016 in Portland, Oregon.

GBA Variants Predict Rapid Progression of Parkinson's Disease

GBA Variants Predict Rapid Progression of Parkinson's Disease

By

The pathogenesis of GBA on PD is unclear, although several studies have pointed to disruptions of different molecular pathways that contribute to disease onset.

Nicotine Exposure During Pregnancy Linked to Tourette Syndrome in Children

Nicotine Exposure During Pregnancy Linked to Tourette Syndrome in Children

By

Smoking during pregnancy has been linked withlong-term neurodevelopmental abnormalities and child behavioral problems.

MRI-Guided Focused Ultrasound Thalamotomy Improves Essential Tremor

MRI-Guided Focused Ultrasound Thalamotomy Improves Essential Tremor

By

Patients in the treatment group experienced significant improvements at 3 months and through 12 months.

Beneficial Effect on Cognition Noted With Music Therapy in PD

Beneficial Effect on Cognition Noted With Music Therapy in PD

The potential role of active music therapy in ameliorating motor and nonmotor symptoms of Parkinson's disease (PD) was examined by researchers.

Statins May Protect Against Parkinson's Disease in Diabetes

Statins May Protect Against Parkinson's Disease in Diabetes

By

All but one type of statin was associated with a dose-dependent neurprotective benefit against Parkinson's.

Differential Diagnosis: Tic Disorders vs Myoclonic Epilepsy

Differential Diagnosis: Tic Disorders vs Myoclonic Epilepsy

By

Myoclonic seizures may be easily mistaken for a possible tic disorder if the proper patient monitoring is not conducted during diagnosis.

When It's Not Alzheimer's: The Differential Diagnosis of Dementia With Lewy Bodies

When It's Not Alzheimer's: The Differential Diagnosis of Dementia With Lewy Bodies

By

According to a 2010 report based on a survey of caregivers of people with DLB, 78% of cases were initially misdiagnosed.

Leukemia Drug May Have Benefits for Parkinson's Disease

Leukemia Drug May Have Benefits for Parkinson's Disease

The drug was generally well-tolerated among study participants.

FDA Approves First Focused Ultrasound Treatment for Essential Tremor

FDA Approves First Focused Ultrasound Treatment for Essential Tremor

By

Patients experienced a 50% improvement in tremor and motor function.

Sign Up for Free e-newsletters